Literature DB >> 19758212

Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.

Gisele Zandman-Goddard1, Yackov Berkun, Ori Barzilai, Mona Boaz, Miri Blank, Maya Ram, Yaniv Sherer, Juan Manuel Anaya, Yehuda Shoenfeld.   

Abstract

Infections may act as environmental triggers for the induction of systemic lupus erythematosus (SLE). In this study, we determine the relationship between disease manifestations of SLE patients and the titers of five Epstein-Barr virus (EBV) Abs. We evaluated the titers of early antigen IgG (EAG), nuclear antigen IgG, viral capsid antigen (VCA) IgG and IgM, and heterophile IgM, using the BioPlex 2200 multiplexed immunoassay method in 260 sera (120 SLE patients and 140 controls). EAG titers were significantly elevated (P < 0.024) in patients with cutaneous symptoms and increased anti-Ro antibody titers (P < 0.005). VCA IgG titers were significantly elevated (P < 0.003) in patients with joint involvement. None of the titers differed by central nervous system or renal involvement or antiphospholipid syndrome. We conclude that exposure to EBV infection may predict a disease phenotype of mild SLE disease with cutaneous and joint manifestations and elevated titers of anti-Ro Abs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758212     DOI: 10.1111/j.1749-6632.2009.04754.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  36 in total

1.  A case of infantile systemic lupus erythematosus with severe lupus nephritis and EBV infection.

Authors:  Natsuko Kishi; Kenichi Suga; Sato Matsuura; Yukiko Kinoshita; Maki Urushihara; Shuji Kondo; Etsuko Kitano; Michiyo Hatanaka; Hajime Kitamura; Tetsuya Sato; Akihiko Maeda; Shoji Kagami
Journal:  CEN Case Rep       Date:  2013-02-14

Review 2.  Infection and autoimmune disease.

Authors:  Asli Gamze Sener; Ilhan Afsar
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

3.  Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.

Authors:  Shir Azrielant; Shmuel Tiosano; Abdulla Watad; Naim Mahroum; Aaron Whitby; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 4.  A novel pathogenetic concept-antiviral immunity in lupus nephritis.

Authors:  Adriana Migliorini; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

5.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 6.  Lupus and Epstein-Barr.

Authors:  Judith A James; Julie M Robertson
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 7.  Infections and systemic lupus erythematosus.

Authors:  S Esposito; S Bosis; M Semino; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

8.  Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.

Authors:  D Csuka; D Simon; R Hóbor; K Uray; Z Prohászka; Z Bánlaki; P K Jani; Á Szilágyi; F Hudecz; K Rajczy; G Beke; A Boros Major; A Tordai; Z Illés; T Berki; L Czirják; G Füst
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

Review 9.  The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.

Authors:  G Füst
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

10.  Hepatitis B carrier state among SLE patients: case-control study.

Authors:  Omer Gendelman; Naim Mahroum; Doron Comaneshter; Pnina Rotman-Pikielny; Arnon D Cohen; Howard Amital; Michael Sherf
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.